CHP Saint-Grégoire

Saint-Grégoire 35760

0 studies enrolling now · 3 studies all time

What they study most

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, Androgen-Resistant Prostatic Cancer, Head and Neck Cancer, Hormone Refractory Prostatic Cancer, Immune Checkpoint Inhibitor, Immunotherapy, Inhibitory Checkpoint Molecule, Prostate Cancer, Prostate Cancer Recurrent

Studies at this site

• Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
• A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed
• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed